| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
EP 560 [D. B., B. V., C. A.] and UMR 8526 [B. Q., A. B.], Centre National de la Recherche Scientifique/Institut Pasteur de Lille/Université Lille 2, Institut de Biologie de Lille, 59021 Lille Cedex, France
Rel/nuclear factor
B transcription factors were shown to have either pro- or antiapoptotic as well as pro- or antiproliferative functions, and it is often assumed that the outcome of their activation depends on the cell type or cellular context. Inconsistent with this assumption, we show here that cRel is able in one cell type to inhibit proliferation, protect against apoptosis induced by tumor necrosis factor
(TNF-
) + cycloheximide (CHX), and increase the basal rate of apoptosis. Both the effects of proliferation inhibition and protection against TNF-
+ CHX-induced apoptosis are massive and occur in the same cells. Using reverse transcription-PCR, Western blot and immunofluorescence, and transactivation assays, we found that the manganese superoxide dismutase (MnSOD), an enzyme that converts O
2 in H2O2, is up-regulated by cRel through a
B site in intron 2. Inhibition of MnSOD induction by antisense oligonucleotides and overexpression of MnSOD respectively reverts and mimics both the antiproliferative and antiapoptotic effects of cRel, suggesting that they both occur via the induction of this gene. On one hand, MnSOD could improve the efficiency of cRel-overexpressing cells in eliminating toxic O
2 produced on TNF-
treatment, explaining why they escape TNF-
-induced apoptosis. On the other hand, cRel-overexpressing cells should accumulate H2O2. We present evidence linking this H2O2 accumulation to the proliferation arrest induced by cRel. Therefore, different effects on proliferation and apoptosis could arise from the induction of MnSOD and thus coexist in cRel-overexpressing cells.
This article has been cited by other articles:
![]() |
Y.-B. Lim, T. J. Park, and I. K. Lim B Cell Translocation Gene 2 Enhances Susceptibility of HeLa Cells to Doxorubicin-induced Oxidative Damage J. Biol. Chem., November 28, 2008; 283(48): 33110 - 33118. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Hrdlickova, J. Nehyba, A. S. Liss, and H. R. Bose Jr. Mechanism of Telomerase Activation by v-Rel and Its Contribution to Transformation J. Virol., January 1, 2006; 80(1): 281 - 295. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Papa, F. Zazzeroni, C. G. Pham, C. Bubici, and G. Franzoso Linking JNK signaling to NF-{kappa}B: a key to survival J. Cell Sci., October 15, 2004; 117(22): 5197 - 5208. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bernard, K. Gosselin, D. Monte, C. Vercamer, F. Bouali, A. Pourtier, B. Vandenbunder, and C. Abbadie Involvement of Rel/Nuclear Factor-{kappa}B Transcription Factors in Keratinocyte Senescence Cancer Res., January 15, 2004; 64(2): 472 - 481. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pizzi, F. Goffi, F. Boroni, M. Benarese, S. E. Perkins, H.-C. Liou, and P. Spano Opposing Roles for NF-kappa B/Rel Factors p65 and c-Rel in the Modulation of Neuron Survival Elicited by Glutamate and Interleukin-1beta J. Biol. Chem., May 31, 2002; 277(23): 20717 - 20723. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bernard, B. Quatannens, B. Vandenbunder, and C. Abbadie Rel/NF-kappa B Transcription Factors Protect against Tumor Necrosis Factor (TNF)-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis by Up-regulating the TRAIL Decoy Receptor DcR1 J. Biol. Chem., July 13, 2001; 276(29): 27322 - 27328. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |